{
    "Subsequent Therapy": {
        "Progression on First-line Therapy": {
            "Systemic Therapy": {
                "Docetaxel": "Progression (See NSCL-21)",
                "Pemetrexed": "Progression (See NSCL-21)",
                "Gemcitabine": "Progression (See NSCL-21)"
            },
            "Immunotherapy (if not previously given)": {
                "Nivolumab": "Progression (See NSCL-21)",
                "Pembrolizumab": "Progression (See NSCL-21)",
                "Atezolizumab": "Progression (See NSCL-21)"
            }
        }
    },
    "footnotes": {
        "1": "See Principles of Systemic Therapy (NSCL-F)."
    }
}